Sports
Biophytis Launches OBA Phase 2 Clinical Study In Obesity With BIO101 (20-Hydroxyecdysone)
(MENAFN - EQS Group) Biophytis / Key word(s): MiscellaneousBiophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) 08-Apr-2024 / 23:00 CET/CEST Biophytis ...
By: menafn
- Apr 09 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS